ArticleOncotarget2017

Pharmacologic characterization of SHR8443, a novel dual inhibitor of phosphatidylinositol 3-kinase and mammalian target of rapamycin.

Chengying Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.